The stock gave multibagger returns of 190 per cent in just 3 months and over 440 per cent in 6 months.

Shares of the company have gained more than 150 per cent in the last six months.

Shares of the company gained more than 160 per cent in the last six months.

Shares of the company gained over 200 per cent in the last one year.

The stock is up over 20 per cent from its 52-week low of Rs 640.55 per share.

In the recent trading sessions, the stock has been hitting back-to-back upper circuits and 52-week highs

Shares of the company gained over 50 per cent in the last six months.

Shares of the company gained over 90 per cent in the last six months.

The company's market capitalization stood at Rs 1,245, and its return on equity is an impressive 55 per cent. Prominent investor Mukul Agarwal has invested in this stock by 1.26 per cent, which gives new investors’ confidence in the company.

Neuland Laboratories, in an impressive Q2FY24 performance, has seen a remarkable 43 per cent year-on-year growth in its Contract Manufacturing Services (CMS) vertical, propelling the company's EBITDA margin to a substantial 33.4 per cent, a remarkable 980 basis points increase YoY. This remarkable progress can be attributed to both higher revenues and a strategic shift towards high-margin business